ICLR vs UNH

ICLR presents a stark contrast between strong deterministic health and deteriorating growth fundamentals. While the Piotroski F-Score of 7/9 indicates a strong financial foundation and the stock trades below its Graham Number ($142.86) and Book Value (P/B 0.95), the recent earnings collapse (-98.7% YoY) is a critical concern. The massive PEG ratio of 19.29 suggests the stock is significantly overvalued relative to its current growth trajectory. Despite analyst 'Buy' recommendations, the technical trend remains bearish and revenue growth has stagnated.

UnitedHealth Group presents a conflicted profile with a stable but mediocre Piotroski F-Score of 4/9 and a significant disconnect between current price ($323.48) and defensive fair value (Graham Number: $175.91). While revenue growth remains robust at 12.3%, the company has suffered a catastrophic collapse in YoY earnings growth (-99.9%), suggesting severe short-term headwinds or one-time accounting shocks. Technical trends are currently bearish (0/100), though a recent one-month bounce and a favorable Forward P/E of 16.08 indicate analyst expectations of a recovery. The stock is currently trading at a significant premium to its intrinsic value, relying heavily on its market dominance and future earnings normalization.